Robert S. Kerbel
机构: Sunnybrook Research Institute
每年引用次数
引用次数
引用: 69,536
H-指数: 127
I10-指数 : 394
出版物: 662
Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
M. G. Brattain , R. Kerbel , S. P. Wu , J. K. V. Willson
Cell Growth & Differentiation 4 ( 2) 115 -123
70
1993
Metronomic chemotherapy (MC) with UFT, cyclophosphamide (CTX) and celecoxib in patients with advanced gastrointestinal cancers: A clinical study with pharmacokinetic (PK) and pharmacodynamic (PD) evaluations
M. Del Tacca , Guido Bocci , G. Brandi , M. Andreuccetti
10th World Congress on Gastrointestinal Cancer (ESMO International Symposium)
2008
Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methothrexate, and daily prednisone (DalCMP) as therapy for metastatic breast cancer (MBC).
D. J. Sutherland , U. Emmenegger , S. Gardner , K. I. Pritchard
Journal of Clinical Oncology 28 1152 -1152
2010
Basement membrane invasion by first trimester human trophoblast: requirement for branched complex-type Asn-linked oligosaccharides.
S. Yagel , R. Kerbel , P. Lala , T. Eldar-Gera
Clinical & Experimental Metastasis 8 ( 4) 305 -317
34
1990
460 Antiangiogenic drug alterations of the tumor microenvironment which can impact chemotherapy efficacy
R. Kerbel , J. Ebos , Y. Shaked
Ejc Supplements 8 ( 7) 149
2010
Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
S. Gately , R. Kerbel
Progress in Experimental Tumor Research 37 179 -192
105
2003
Palliation of relapsed aggressive histology NHL with high-dose celecoxib and 'metronomic' low-dose cyclophosphamide.
R. Buckstein , M. Crump , Y. Shaked , C. Foden
Journal of Clinical Oncology 22 3016 -3016
6
2004
75 INVITED Differential and Unexpected Impact of Adjuvant Versus Metastatic Antiangiogenic Therapy
R. Kerbel
European Journal of Cancer 47 S20 -S21
2011
S14 Antiangiogenic therapy for breast cancer: What now?
R. Kerbel
The Breast 20
1
2011
Preliminary results of a phase II study of continuous low dose metronomic (LDM) cyclophosphamide (CTX) and celecoxib (CEL) for asymptomatic hormone refractory prostate cancer (HRPC) with assessment of anti-angiogenic biomarkers
S. R. Berry , Y. Ko , U. Emmenegger , Y. Shaked
Journal of Clinical Oncology 25 14046 -14046
1
2007
CLASSIFICATION OF THYMUS-DERIVED AND MARROW-DERIVED LYMPHOCYTES BY DEMONSTRATION OF THEIR ANTIGEN-BINDING CHARACTERISTICS
J. S. Haskill , B. E. Elliott , R. Kerbel , M. A. Axelrad
Journal of Experimental Medicine 135 ( 6) 1410 -1415
46
1972
Generation of a Plasma Microrna (Mirna) Signature Predicting Response to Metronomic Chemotherapy (Mc) for Advanced Breast Cancer (Abc)
U. Emmenegger , B.A. Sousa , V.C. Hoang , A. Chow
Annals of Oncology 25 iv62
1
2014
Forty-Year Journey of Angiogenesis Translational Research
Y. Cao , J. Arbiser , R. J. D'Amato , P. A. D'Amore
Science Translational Medicine 3 ( 114)
215
2011
Microbubble ultrasound compared to dynamic contrast MRI and CT for the assessment of vascular response to sunitinib in renal cell carcinoma.
G. A. Bjarnason , J. M. Hudson , C. Bailey , C. R. Lee
Journal of Clinical Oncology 28
1
2010
NT-02 * EARLY TREATMENT OF HER2-AMPLIFIED BRAIN TUMOURS WITH TARGETED NK-92 CELLS AND FOCUSED ULTRASOUND IMPROVES SURVIVAL
R. Alkins , A. Burgess , G. Francia , R. Kerbel
Neuro-Oncology 16 ( suppl 5) v159 -v159
2014
Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm.
Kerbel Rs
American Journal of Pathology 141 ( 3) 519 -524
84
1992
Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
Breitman Ml , Kerbel Rs , Waghorne C
Oncogene 1 ( 2) 149
40
1987
Immunologic studies of membrane mutants of a highly metastatic murine tumor.
Kerbel Rs
American Journal of Pathology 97 ( 3) 609 -622
68
1979
Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors.
Kerbel Rs , St Croix B , Rak J , Florenes Va
Human Cell 9 ( 4) 257
59
1996
Relevance of spontaneous in vivo tumor-host cell fusion to tumor progression and metastasis evaluated using a series of lectin-resistant mutant tumor sublines.
Donaghue Tp , Nestel Fp , Lagarde Ae , Dennis Jw
Symposium on Fundamental Cancer Research 36 47 -79
12
1983